Skin & hair

When Alopecia Takes All the Hair

Save

Losing every hair on your head — or your whole body — is one of the hardest versions of an already unpredictable disease. Alopecia totalis and universalis were, for a long time, conditions with little to offer. That has shifted. This explains what these diagnoses mean, how severity is measured, why pattern-baldness treatments do not apply, and what oral JAK inhibitors have and have not changed.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What alopecia totalis and universalis are

Alopecia totalis means the complete loss of hair on the scalp; alopecia universalis means the loss of hair across the whole body, including the eyebrows, eyelashes, beard, and body hair. Both are the most extensive forms of alopecia areata, an autoimmune disease in which the immune system mistakenly attacks the hair follicles and the hair falls out 1.

The course is unpredictable. Hair can shed suddenly, regrow on its own, and fall again, and the pattern is hard to forecast for any one person. Crucially, the follicles are usually not destroyed — they go dormant rather than dying — which is why regrowth remains biologically possible even after years without hair, and why there is no cure but treatments can still coax hair back 1. That is a real difference from scarring hair loss, where the follicle is permanently lost. Alopecia beyond the scalp, when the brows and lashes go too, often carries its own practical and emotional weight, separate from the bald scalp itself.

How severity is measured: the SALT score

Dermatologists measure the extent of alopecia areata with the SALT score — the Severity of Alopecia Tool — which estimates the percentage of the scalp that has lost hair. A score of 0 means a full head of hair and 100 means none. Alopecia totalis sits at essentially 100 percent scalp loss, and universalis adds the loss of body hair on top of that.

Knowing how alopecia areata severity is measured matters because the number guides treatment and tracks whether it is working. The SALT score alopecia specialists use is also how research defines success: regrowth to a SALT score of 20 or below — meaning at least 80 percent of the scalp is covered again — was the benchmark used in the pivotal pill trials 2. So a target like "SALT 20 or less" that you might read about is a specific, meaningful goal rather than jargon, and it gives you and a clinician a shared way to talk about alopecia severity and progress over months.

Why older treatments often fall short at this extent

When alopecia areata is patchy, dermatologists often start with treatments applied to the affected skin — corticosteroid injections into the bald patches, potent topical steroids, or contact immunotherapy that provokes a controlled reaction to nudge regrowth. These can work well for limited disease. When almost all the hair is gone, as in totalis and universalis, those local approaches rarely restore a full head of hair, and that is what moves the conversation toward systemic treatment.

A clarification saves a lot of wasted money here: this is not pattern baldness. The foams and pills that help androgenetic alopecia — minoxidil and finasteride — target a hormone- and age-driven thinning 3, and they are not treatments for autoimmune total hair loss. Expecting them to regrow hair in alopecia universalis is a common and costly mistake. Looking at hair-loss treatments, ranked by the evidence, makes the point plain: the underlying condition, not the shared symptom of "hair loss," decides which therapy has any chance of working, and it is the extent-based escalation of alopecia areata — not a baldness ladder — that applies here.

The systemic option: oral JAK inhibitors

The biggest shift in treating severe alopecia areata is a class of pills called JAK inhibitors, which quiet the immune signaling that drives follicles into dormancy. In two large phase 3 trials, the oral JAK inhibitor baricitinib produced significantly more hair regrowth than placebo in adults with severe disease, and it became the first systemic therapy approved specifically for alopecia areata 2. Other JAK inhibitor pills for alopecia areata have followed it to approval.

These are the tools clinicians now consider when disease is extensive, including totalis and universalis, and they are where the phrase jak inhibitors for alopecia usually points. A few honest caveats travel with them. Regrowth takes months, is not guaranteed, and hair often sheds again if the medicine is stopped, so it tends to be an ongoing treatment rather than a short course. Because JAK inhibitors act on the immune system, they call for baseline and ongoing monitoring, which is why they are prescribed and followed by a dermatologist rather than started casually. Whether one fits — weighing the possible benefit against the monitoring and risks — is exactly the alopecia areata treatment conversation worth having in person.

What to expect from treatment, realistically

Regrowth in alopecia totalis and universalis is slow and uneven. When it comes, it usually takes months to appear and longer to fill in, and the response is often partial rather than complete, especially in the most extensive disease. Eyebrows and eyelashes can regrow on their own timeline, sometimes lagging behind the scalp and sometimes leading it.

Relapse is common when treatment stops, which is part of why this is a long-term relationship with a clinician rather than a course you finish and forget. Not everyone responds, and there is still no cure; the honest goal is meaningful regrowth and stability, not a promise of a full head of hair back 1. Setting that expectation early makes the whole process less punishing, because progress in this disease is measured in seasons, not weeks. A dermatologist who treats these conditions regularly is the right person to weigh what is realistic for your particular pattern and history.

Living with total hair loss while you decide

Treatment decisions take time, and life keeps going in the meantime. Many people use wigs, hairpieces, or medical-grade cranial prostheses, and some insurers will cover a prosthesis when it is documented as medically necessary rather than cosmetic. Microblading or tattooing can stand in for lost eyebrows, and there are cosmetic options for framing the eyes when the lashes are gone.

Universalis removes hair that quietly does a job. Eyelashes shield the eyes from dust and sweat, and nasal hair filters the air, so people without them often find sunglasses, wraparound eyewear, and lubricating eye drops genuinely useful rather than vain. A newly bare scalp sunburns easily and benefits from a hat or sunscreen. And the emotional weight of losing all of your hair is real and worth naming out loud — many people find that support groups and counseling help as much as any cream, and reaching for them is a sign of coping well, not poorly.

Common questions

Alopecia totalis is the complete loss of hair on the scalp. Alopecia universalis goes further, with loss of hair across the whole body — eyebrows, eyelashes, beard, and body hair. Both are the most extensive presentations of alopecia areata, the same underlying autoimmune disease, just at a larger scale.

It can. Because the follicles usually go dormant rather than dying, regrowth remains possible even after years without hair. It is not guaranteed and is often slow and partial, but the biological capacity is preserved, which is what treatments like JAK inhibitors try to reactivate.

No. Minoxidil and finasteride are treatments for androgenetic alopecia — the hormone- and age-driven pattern thinning — not for the autoimmune hair loss of alopecia areata. Expecting them to regrow hair in totalis or universalis is a common and expensive mistake, because they target a different condition entirely.

Dermatologists use the SALT score, which estimates the percentage of the scalp missing hair, from 0 (full coverage) to 100 (none). It guides treatment choices and tracks response over time. Research often defines success as regrowth to a SALT score of 20 or below, meaning at least 80 percent scalp coverage.

No. JAK inhibitors can regrow hair in severe alopecia areata, and were the first systemic treatment approved for it, but they are not a cure. Regrowth takes months, is not guaranteed, and hair often sheds again if the medicine stops, so treatment tends to be ongoing and requires monitoring by a dermatologist.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When hair loss needs a closer look

  • —Patches of hair loss where the scalp is red, scaly, scarred, painful, or shiny and smooth — features that can point to a scarring alopecia, which permanently destroys follicles and is treated urgently and differently.
  • —New hair loss alongside fatigue, unexplained weight change, or sensitivity to heat or cold, which can signal a thyroid disorder worth testing.
  • —Fever, chills, or other signs of a serious infection while taking a JAK inhibitor, which suppresses part of the immune response.

This explains how alopecia totalis and universalis are generally treated; it is not medical advice or a prescription. Which treatment fits, and whether a systemic medicine is appropriate, is a decision for you and a dermatologist who can examine you.

References

  1. 1.National Institute of Arthritis and Musculoskeletal and Skin Diseases (2024). Alopecia Areata. NIH / NIAMS. link ✓Alopecia areata is an autoimmune disease in which the immune system attacks hair follicles; its course is unpredictable, there is no cure, and treatments can promote regrowth.
  2. 2.King B, Ohyama M, Kwon O, et al. (2022). Two Phase 3 Trials of Baricitinib for Alopecia Areata. New England Journal of Medicine. doi:10.1056/NEJMoa2110343In two phase 3 trials, oral baricitinib produced significantly more hair regrowth than placebo (SALT score of 20 or below) in adults with severe alopecia areata, the basis for the first systemic approval in the disease.
  3. 3.Adil A, Godwin M (2017). The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. Journal of the American Academy of Dermatology. PMID 28396101 ✓Minoxidil and finasteride promote hair growth in androgenetic alopecia — a distinct, hormone- and age-driven condition — which is why they are not the treatment for autoimmune alopecia areata.

3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy

← Back to the health library